文献速递中医内科中药与中成药合理使用

补阳还五汤通过抑制内质网应激介导的肺泡II型上皮细胞凋亡改善博来霉素诱导的大鼠肺纤维化

Buyang Huanwu decoction ameliorates bleomycin-induced pulmonary fibrosis in rats by attenuating the apoptosis of alveolar type II epithelial cells mediated by endoplasmic reticulum stress.
PubMed 文献 · J Ethnopharmacol · 2023-10-07

本研究探讨补阳还五汤对博来霉素诱导的大鼠肺纤维化的治疗作用及机制。采用UPLC-MS/MS控制质量,建立大鼠模型,通过肺功能、病理染色和羟脯氨酸检测评估疗效,并检测内质网应激介导的肺泡II型上皮细胞凋亡。结果显示补阳还五汤改善肺功能下降、纤维化病理改变和胶原沉积,其机制与抑制PERK-ATF4-CHOP通路、调节Bcl-2/Bax和CASP3 cleavage有关。

要点

  • 补阳还五汤可改善博来霉素诱导的大鼠肺纤维化。
  • 其机制与抑制内质网应激介导的肺泡II型上皮细胞凋亡相关。
  • 作用涉及上调Bcl-2、下调Bax及抑制CASP3 cleavage。

核心结论

  • 补阳还五汤通过抑制内质网应激介导的肺泡II型上皮细胞凋亡,改善博来霉素诱导的大鼠肺纤维化。

研究设计与样本

  • 采用UPLC-MS/MS鉴定补阳还五汤质量,建立博来霉素单次气管内注射诱导的IPF大鼠模型,进行肺功能测试、H&E染色、Masson染色和羟脯氨酸测定,并通过TUNEL染色、Western blot、实时荧光定量PCR和免疫荧光共染色探究机制。

主要发现

  • 补阳还五汤改善博来霉素诱导的大鼠肺功能下降、肺纤维化病理改变和胶原沉积。
  • 补阳还五汤增加Bcl-2蛋白表达,降低Bax蛋白表达,并通过抑制PERK-ATF4-CHOP通路活化抑制CASP3 cleavage,从而减轻博来霉素诱导的AEC2s凋亡。

临床怎么用

  • 该研究为补阳还五汤临床治疗特发性肺纤维化提供基础研究依据,但临床决策需结合患者具体证候和进一步临床证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: According to the theory of traditional Chinese medicine, the pathogenesis of idiopathic pulmonary fibrosis (IPF) can be attributed to qi deficiency and blood stasis. Buyang Huanwu decoction (BHD), a representative Chinese herbal prescription for qi deficiency and blood stasis syndrome, is widely used to treat IPF in clinical practice. However, its potential mechanisms against IPF remain unclear. AIMS OF THE STUDY: This study was carried out to explore the therapeutic effects and underlying mechanisms of BHD on bleomycin (BLM)-induced pulmonary fibrosis in rats. MATERIALS AND METHODS: UPLC-MS/MS method was performed to identify the quality of BHD used in this study. Concurrently, a IPF rat model was established by single intratracheal injection of BLM. Pulmonary function test, H&E staining, Masson staining, hydroxyproline assay were conducted to evaluate the therapeutic effects of BHD on BLM-induced pulmonary fibrosis in rats, and the regulatory effect of BHD on endoplasmic reticulum stress (ERS)-mediated alveolar type II epithelial cells (AEC2s) apoptosis in rats was further investigated by TUNEL staining, Western blot, real-time fluorescence quantitative PCR and immunofluorescence co-staining to reveal the potential mechanisms of BHD against IPF. RESULTS: The UPLC-MS/MS analysis showed that the BHD we used complied with the relevant quality control standards. The data from animal experiments confirmed that BHD administration ameliorated BLM-induced pulmonary function decline, lung fibrotic pathological changes and collagen deposition in rats. Further mechanism study revealed that BHD increased the Bcl-2 protein expression, decreased the Bax protein expression and inhibited the cleavage of CASP3 via suppressing the activation of PERK-ATF4-CHOP pathway under continuous ERS, thereby alleviating BLM-induced AEC2s apoptosis of rats. CONCLUSION: This study demonstrated that BHD ameliorated BLM-induced pulmonary fibrosis in rats by suppressing ERS-mediated AEC2s apoptosis. Our findings can provide some fundamental research basis for the clinical application of BHD in the treatment of IPF.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhou P, Wu X, Chen K, et al. Buyang Huanwu decoction ameliorates bleomycin-induced pulmonary fibrosis in rats by attenuating the apoptosis of alveolar type II epithelial cells mediated by endoplasmic reticulum stress. J Ethnopharmacol. 2023. PMID: 37813290. doi:10.1016/j.jep.2023.117300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。